New HHS Rule Expands Healthcare Access and Enhances Marketplace Guidelines
April 3rd 2024The efforts of the final rule aim to simplify the enrollment process for low-income consumers, provide states with more flexibility in offering routine adult dental services and set guidelines to create access to in-network providers.
Read More
Muthu Vaduganathan Gives Insights on the Cost Effectiveness of SGLT2 Inhibitors
March 29th 2024In this second part of a two-part video series, MHE editors spoke with Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, about the cost effectiveness of SGLT2 inhibitors.
Read More
The Departments of Health and Human Services (HHS), Labor, and the Treasury, released final rules on short-term, limited-duration insurance (STLDI) and independent, non-coordinated excepted benefits coverage, addressing issues related to the low-quality insurance, or "junk insurance" plans.
Read More
Muthiah “Muthu” Vaduganathan Discusses the Role of SGLT2 Inhibitors in Heart Failure Treatment
March 27th 2024Editors of Managed Healthcare Executive spoke with Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, about the evolving treatment landscape for heart failure, emphasizing the use of SGLT2 inhibitors alongside other foundational therapies.
Read More
With aging populations, osteoporosis rates are set to increase, and researchers are looking for the next innovative drug to help prevent or manage the bone disease as there is currently no drug that completely does so effectively, according to a recent study published in Advanced Science.
Read More
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with Ceci Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Read More
Chronic Health Conditions and Access to Care
March 21st 2024Results from the 2024 State of Patient Access report by the PAN Foundation shared that patients with chronic health conditions, in particular, face barriers to accessing quality care due to costs, coverage gaps and social challenges with healthcare professionals (HCPs).
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and Ceci Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Read More
Positive Results for Ruxolitinib Cream in Children with Atopic Dermatitis Presented in Ongoing Study
March 18th 2024Ruxolitinib cream showed positive results in children 2- to 11-years-old with mild to moderate atopic dermatitis (AD), according to data of a poster presented at the American Academy of Dermatology Annual Meeting in San Diego from March 8 to 12.
Read More
Healthcare Ready, a nonprofit organization committed to protecting the U.S. healthcare system against disasters and pandemics, recently concluded an initiative aimed to understand the consequences of the COVID-19 pandemic and other disaster-related threats on the healthcare workforce.
Read More
The Rise in ‘Menopause’ and ‘Mommy Makeovers’: Navigating Aging and Hormonal Shifts with Aesthetics
March 13th 2024As women age, hormonal shifts during menopause often bring visible changes in their physical appearance. Cynthia Elliott, M.D., owner and primary practitioner at Skinspirations, shed light on the concept of "menopause makeovers" and how medical aesthetic procedures can address these changes toward women.
Read More
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this second part of a video series, AMCP CEO Susan Cantrell addressed the impact of high prescription drug prices on underserved communities, highlighting disparities in access caused by the pandemic's effects on minority populations. On the industry blame debate, she urged collaborative solutions, mentioning AMCP's engagement with diverse stakeholders to find comprehensive, patient-centric solutions and advocate for policy changes like the MVP Act to address rising costs and access challenges.
Read More
ARPA-H Unveils $100M Funding for Biden-Harris Women's Health Initiative
February 26th 2024This is ARPA-H’s first major deliverable of the White House Initiative on Women’s Health Research since the Agency was created in 2022 as part of President Biden’s bipartisan Unity Agenda, seeking to advance and accelerate health solutions.
Read More
Women Leaders Rally and Urge Health Insurers to Comply with ACA Birth Control Coverage
February 22nd 2024A coalition of women, including members of the Democratic Women’s Caucus (DWC), Pro-Choice Caucus Contraception & Family Planning Task Force, and Senators, took the lead in rallying over 150 House and Senate Democratic colleagues, after the large group of lawmakers wrote a letter yesterday to America’s Health Insurance Plans (AHIP) President and CEO Mike Tuffin addressing that AHIP’s “members are not complying with the Affordable Care Act contraception coverage requirement.."
Read More